Why Moderna Stock Is Down 25% In Recent Weeks - Forbes

Dec 29, 2020  · Moderna’s stock has declined by roughly 25% over the last two weeks. While news from the company has been largely positive, with its Covid-19 vaccine receiving …


Install CouponFollow Chrome Extension   CouponFollow Extension

25%
OFF

Why Moderna Stock Is Down 25% In Recent Weeks - Forbes

2 weeks from now

Dec 29, 2020  · Moderna’s stock has declined by roughly 25% over the last two weeks. While news from the company has been largely positive, with its Covid-19 vaccine receiving …

forbes.com

25%
OFF

Why Moderna Stock Is Down 25% Over The Last Month - Forbes

2 weeks from now

Mar 5, 2021  · Firstly, demand for Moderna’s Covid-19 shot is strong. For example, in late January, the company said that it was in talks with the U.S. government to sell 100 million more doses …

forbes.com

1%
OFF

What’s Behind The Recent Rise In MRNA Stock? - Forbes

2 weeks from now

Jan 8, 2025  · The Covid-19 positivity rate has also seen a rise to 7.1% this past week, versus the 5.5% figure for the past four weeks. ... The stock price of Moderna ... -45% in 2023, and -58% …

forbes.com

20%
OFF

Moderna Dropped By 20% This Week -- Is It A Smart Buy Right Now?

2 weeks from now

Jan 16, 2025  · The main reason for this week's decline is that Moderna lowered its 2025 full-year revenue guidance, and by a wide margin. The prior forecast called for $2.5 billion to $3.5 …

fool.com

21%
OFF

Why Moderna Stock Just Crashed 21% - Yahoo Finance

2 weeks from now

Jan 13, 2025  · Moderna's (NASDAQ: MRNA) sales are slowing down, and Moderna stock is going down -- a lot. The coronavirus vaccine maker's shares plunged 21.2% through 10:20 a.m. ET …

yahoo.com

21%
OFF

Why Moderna Stock Just Crashed 21% - The Motley Fool

2 weeks from now

Jan 13, 2025  · CEO Stéphane Bancel said Moderna has cut its "cash operating cost by over 25 percent compared to 2023" and plans to make further cost cuts of $1 billion in 2025 and $500 …

fool.com

20%
OFF

Moderna Stock Falls 20% In A Month: Time To Sell Or Hold?

2 weeks from now

Oct 16, 2024  · Moderna expects to generate revenues between $2.5 billion and $3.5 billion in 2025. For 2026-2028, management expects sales to witness a CAGR of more than 25%, …

yahoo.com

79%
OFF

Down 79%, Is Moderna Stock A Bad-News Buy On The Dip?

2 weeks from now

Jan 16, 2025  · Moderna (NASDAQ: MRNA) shareholders have been having a rough time lately. The biotech stock rocketed higher last spring, but the gains didn't last long. Since reaching a …

yahoo.com

$141.64
OFF

Moderna Stock Is Having Another Very Bad Day. Here’s Why. - MSN

2 weeks from now

The stock was down to $141.64 early Wednesday, down from a Friday closing price of $166.61 but well ahead of where it began the month, at $110.31. ... Moderna confirmed to Barron’s last …

msn.com

66%
OFF

Moderna Stock Plunges Despite ‘Vaccine Day’ Touting 31 New

2 weeks from now

Mar 25, 2022  · Even after a recent recovery, Moderna shares have crashed 66% from an all-time high of $497 set in August. ... Jefferies analyst Michael Yee said the stock drawback has …

forbes.com

21%
OFF

Moderna Stock Is Sliding Wednesday: Here's Why - Benzinga

2 weeks from now

Recent Markets. January 29, 2025 1: ... 2025 1:06 PM 2 min read. Moderna Stock Is Sliding Wednesday: Here's Why. by Adam Eckert Benzinga ... Moderna shares were down 8.21% at …

benzinga.com

25%
OFF

Why Moderna Stock Is Down 25% In Recent Weeks | Nasdaq

2 weeks from now

Dec 30, 2020  · Moderna’s (NASDAQ: MRNA) stock has declined by roughly 25% over the last two weeks. While news from the company has been largely positive, with its Covid-19 vaccine …

nasdaq.com

39%
OFF

Moderna Stock Down 39% In Three Months: Buy The Dip Or Wait?

2 weeks from now

Dec 23, 2024  · Despite being a pioneer in developing one of the first and most widely used COVID-19 vaccines, shares of Moderna (MRNA Quick Quote MRNA - Free Report) have been …

zacks.com

4%
OFF

Moderna Stock Crash Intensifies: Losses Top $130 Billion - Forbes

2 weeks from now

Jan 21, 2022  · Moderna stock fell 4.4% Friday to an eight-month low of $160, pushing shares down more than 20% over the past week amid growing research suggesting Moderna’s Covid …

forbes.com

25%
OFF

Why Moderna Stock Is Down 25% Over The Last Month - Nasdaq

2 weeks from now

Feb 9, 2021  · See our indicative theme of Covid-19 Vaccine stocks which includes U.S.-listed pharma and biotech companies. The theme is up about 5x over the last 2 years. [2/9/2021] …

nasdaq.com

50%
OFF

Down 50% From Its Highs, Moderna Stock Looks Like Good Value

2 weeks from now

Nov 9, 2021  · Moderna stock declined by about 30% over the last week (five trading days) following the company’s weaker than expected Q3 2021 results. While Moderna’s revenue for …

forbes.com

$12
OFF

Moderna Earnings Beat Estimates. Why The Stock Is Sinking. - MSN

2 weeks from now

Moderna’s net income shot up to $12.2 billion in 2021, and $8.3 billion in 2022, as the company launched its Covid-19 vaccine. It’s been losing money since last year, but the company has …

msn.com

5%
OFF

Why Moderna Stock Is Down By 5% Today - Yahoo Finance

2 weeks from now

Jan 11, 2022  · Analysts expect that Moderna will report earnings of $27.85 in 2022, so the stock is trading at roughly 8 forward P/E, which is certainly cheap for the current market environment.

yahoo.com

75%
OFF

Why 75% Of Businesses Aren’t Seeing ROI From AI Yet - Forbes

2 weeks from now

Jan 30, 2025  · As trading opened Thursday, Microsoft stock was down more than 5%. CFO Amy Hood and CEO Satya Nadella said on the earnings call that Microsoft’s growth in this area is …

forbes.com

12%
OFF

Will Moderna Stock Rally After 12% Decline Last Week? - Forbes

2 weeks from now

Mar 25, 2021  · Moderna stock has declined by about -12% over the last week (five trading days), compared to the S&P 500 which is down by about -1.2% over the same period. Although there …

forbes.com

FAQs about Why Moderna Stock Is Down 25% In Recent Weeks - Forbes Coupon?

Is Moderna stock going down?

The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*. Moderna's (NASDAQ: MRNA) sales are slowing down, and Moderna stock is going down -- a lot. ...

Why did Moderna stock gain downside momentum today?

Shares of Moderna gained downside momentum today as traders took some profits off the table after yesterday’s rally. Moderna has recently reported that it expected to record revenue of $18.5 billion from existing contracts for the delivery of COVID-19 vaccine in 2022. ...

Will Moderna lose money in 4 years?

Analysts think Moderna will lose money for at least four years. Moderna 's (MRNA -2.31%) sales are slowing down, and Moderna stock is going down -- a lot. The coronavirus vaccine maker's shares plunged 21.2% through 10:20 a.m. ET Monday after it updated investors on its 2024 performance and released new guidance for 2025. ...

Why did Moderna's revenue decline this week?

The main reason for this week's decline is that Moderna lowered its 2025 full-year revenue guidance, and by a wide margin. The prior forecast called for $2.5 billion to $3.5 billion in sales for 2025, but the updated guidance calls for $1.5 billion to $2.5 billion. At the midpoint, that represents a $1 billion reduction, or 50% lower revenue. ...

Is Moderna a good stock to buy?

From a valuation standpoint, Moderna appears attractive compared to the industry. Going by the price/sales (P/S) ratio, the company’s shares currently trade at 4.36, trailing 12-month sales value, lower than 8.21 for the industry. Estimates for Moderna’s 2024 loss per share have increased from $9.37 to $9.85 in the past 60 days. ...

What happened to Moderna shares?

Shares of Moderna have plunged 67% from an all-time closing high of $484 on August 9, wiping out about $133 billion from the firm’s market capitalization, which now stands at roughly $65 billion. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension